Monday, August 26, 2013 7:21:50 AM
Item 4 Management’s discussion and analysis of financial condition and results of operation.
Overview
During Q2 the Company has continued its aggressive development of mobile applications for our technologies; and continues to focus on initiatives in the Washington/Maryland capital region to develop solutions that will reduce the impact of hospital readmissions, one of the major financial burdens on the healthcare system. Discussions for a deployment of transitional care technology in the Province of Quebec are under way, ideally to be deployed in synch with the American capital region. We continue to work with our partners to secure contracts for the national deployment of a national emergency response network database.
We refer to the three month period ended March 31 2013 as Q3 2013.
At December 31, 2012, the Company had a working capital of $361,026 as compared to a working capital of $409,213 for Q2 2013, and has incurred losses of $31,193,995 since inception.
We had revenues of $507,320 for Q3 2013 with a net income of $84,911.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM